Your browser doesn't support javascript.
loading
A Protocol for Improved Precision and Increased Confidence in Nanoparticle Tracking Analysis Concentration Measurements between 50 and 120 nm in Biological Fluids.
Parsons, Martin E M; McParland, Damien; Szklanna, Paulina B; Guang, Matthew Ho Zhi; O'Connell, Karen; O'Connor, Hugh D; McGuigan, Christopher; Ní Áinle, Fionnuala; McCann, Amanda; Maguire, Patricia B.
Afiliación
  • Parsons MEM; SPHERE Research Group, UCD Conway Institute, University College Dublin (UCD), Dublin, Ireland.
  • McParland D; School of Biomolecular and Biomedical Science, University College Dublin (UCD), Dublin, Ireland.
  • Szklanna PB; School of Mathematics and Statistics, University College Dublin (UCD), Dublin, Ireland.
  • Guang MHZ; SPHERE Research Group, UCD Conway Institute, University College Dublin (UCD), Dublin, Ireland.
  • O'Connell K; School of Biomolecular and Biomedical Science, University College Dublin (UCD), Dublin, Ireland.
  • O'Connor HD; School of Medicine, College of Health and Agricultural Science (CHAS), University College Dublin (UCD), Dublin, Ireland.
  • McGuigan C; UCD Conway Institute of Biomolecular and Biomedical Science, University College Dublin (UCD), Dublin, Ireland.
  • Ní Áinle F; School of Medicine, College of Health and Agricultural Science (CHAS), University College Dublin (UCD), Dublin, Ireland.
  • McCann A; UCD Conway Institute of Biomolecular and Biomedical Science, University College Dublin (UCD), Dublin, Ireland.
  • Maguire PB; Department of Neurology, St. Vincent's University Hospital, Dublin, Ireland.
Front Cardiovasc Med ; 4: 68, 2017.
Article en En | MEDLINE | ID: mdl-29164135
ABSTRACT
Nanoparticle tracking analysis (NTA) can be used to quantitate extracellular vesicles (EVs) in biological samples and is widely considered a useful diagnostic tool to detect disease. However, accurately profiling EVs can be challenging due to their small size and heterogeneity. Here, we aimed to provide a protocol to facilitate high-precision particle quantitation by NTA in plasma, the supernatant of activated purified platelets [the platelet releasate (PR)] and in serum, to increase confidence in NTA particle enumeration. The overall variance and the precision of NTA measurements were quantified by root mean square error and relative standard error. Using a bootstrapping approach, we found that increasing video replicates from 5 s × 60 s to 25 s × 60 s captures led to a reduction in overall variance and a reproducible increase in the precision of NTA particle-concentration quantitation for all three biofluids. We then validated our approach in an extended cohort of 32 healthy donors. Our results indicate that for vesicles sized between 50 and 120 nm, the precision of routine NTA measurements in serum, plasma, and PR can be significantly improved by increasing the number of video replicates captured. Our protocol provides a common platform to statistical compare particle size distribution profiles in the exosomal-vesicle size range across a variety of biofluids and in both healthy donor and patient groups.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Front Cardiovasc Med Año: 2017 Tipo del documento: Article País de afiliación: Irlanda

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Front Cardiovasc Med Año: 2017 Tipo del documento: Article País de afiliación: Irlanda